USPTO serial 79268012
RIBOTECT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 13, 2020
- Examiner
- RUTLAND, BARBARA A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with RIBOTECT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $1,275
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Monica Riva Talley
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.1101 K Street, NW10th FloorWashington, DC 20005Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Chemical reagents for medical and veterinary purposes; Medical and pharmaceutical preparations comprising liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions for the treatment and prevention of cancerous diseases, infectious diseases, autoimmune disorders, genetic defects or metabolic disorders; Medical and pharmaceutical preparations comprising, in particular, liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions and comprising additional active ingredients, in particular proteins or nucleid acids for the treatment and prevention of cancerous diseases, infectious diseases, autoimmune disorders, genetic defects or metabolic disorders; Carriers and carrier systems, namely, drug delivery agents in the form of powders, tablets, liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions and capsules that provide controlled release of the active ingredients for pharmaceuticals for use in the treatment of cancer, infectious diseases, autoimmune disorders, genetic defects, and metabolic disorders | ACTIVE | — |
| 042 | Scientific research for medical and veterinary purposes, in particular for treatment of cancer, infectious diseases, autoimmune disorders, genetic defects, and metabolic disorders, using liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or emulsions | ACTIVE | — |
| 044 | Medical and veterinary services in connection with cancer diseases, infectious diseases, autoimmune disorders, genetic defects, and metabolic disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BioNTech RNA Pharmaceuticals GmbH
- Other trademarks owned by BioNTech RNA Pharmaceuticals GmbH
- Other trademarks owned by BioNTech SE
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named RIBOTECT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 13, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jan 31, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 30, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 30, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| May 30, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 30, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 30, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 30, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 19, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Feb 20, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 29, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 29, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 13, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 13, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 31, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 28, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 28, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 15, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 15, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 8, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 20, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 28, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 28, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 28, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 20, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 30, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 30, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 10, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 9, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 4, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 8, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 2, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 26, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |